Teva Pharma Industries Ltd ADR
Price & Volume
Stats
See more52W Range | $14.99-$37.35 |
Market Cap | $38.3B |
Shares Short | 32M |
Financials
See moreRevenue (12 Mos) | $17.3B |
Revenue Growth (YoY) | 2.3% |
Gross Profit (12 Mos) | $9B |
Diluted EPS | $1.34 |
News
See moreYahoo Finance • 5 days ago
Novartis vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?
Yahoo Finance • 5 days ago
Teva And Polpharma Biologics Ink Global Licensing Deal For Ocrevus Biosimilar
Yahoo Finance • 8 days ago
Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?
Yahoo Finance • 11 days ago
Arcutis vs. Vertex: Which Pharmaceutical Maker Stock Is a Better Buy in 2026?
About
CEO | Mr. Richard D. Francis |
CFO | Mr. Eliyahu Sharon Kalif |
Address | 124 Dvora HaNevi?a St., Tel Aviv-Yafo, Israel, 6944020 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 31,173 |